Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway
- PMID: 7505797
- PMCID: PMC2191336
- DOI: 10.1084/jem.179.1.167
Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway
Abstract
Enforced expression of p210bcr-abl transforms interleukin 3 (IL-3)-dependent hematopoietic cell lines to growth factor-independent proliferation. It has been demonstrated that nonreceptor tyrosine kinase oncogenes may couple to the p21ras pathway to exert their transforming effect. In particular, p210bcr-abl was recently found to effect p21ras activation in hematopoietic cells. In this context, experiments were performed to evaluate a protein signaling pathway by which p210bcr-abl might regulate p21ras. It was asked whether Shc p46/p52, a protein containing a src-homology region 2 (SH2) domain, and known to function upstream from p21ras, might form specific complexes with p210bcr-abl and thus, possibly alter p21ras activity by coupling to the guanine nucleotide exchange factor (Sos/CDC25) through the Grb2 protein-Sos complex. This latter complex has been previously demonstrated to occur ubiquitously. We found that p210bcr-abl formed a specific complex with Shc and with Grb2 in three different murine cell lines transfected with a p210bcr-abl expression vector. There appeared to be a higher order complex containing Shc, Grb2, and bcr-abl proteins. In contrast to p210bcr-abl transformed cells, in which there was constitutive tight association between Grb2 and Shc, binding between Grb2 and Shc was Steel factor (SLF)-dependent in a SLF-responsive, nontransformed parental cell line. The SLF-dependent association between Grb2 and Shc in nontransformed cells involved formation of a complex of Grb2 with c-kit receptor after SLF treatment. Thus, p210bcr-abl appears to function in a hematopoietic p21ras activation pathway to allow growth factor-independent coupling between Grb2, which exists in a complex with the guanine nucleotide exchange factor (Sos), and p21ras. Shc may not be required for Grb2-c-kit interaction, because it fails to bind strongly to c-kit.
Similar articles
-
Multiple hemopoietins, with the exception of interleukin-4, induce modification of Shc and mSos1, but not their translocation.J Biol Chem. 1994 Aug 19;269(33):21165-76. J Biol Chem. 1994. PMID: 8063737
-
Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.Oncogene. 1997 May 8;14(18):2217-28. doi: 10.1038/sj.onc.1201049. Oncogene. 1997. PMID: 9174058
-
Shc phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin-3, and steel factor and is constitutively increased by p210BCR/ABL.J Biol Chem. 1994 Feb 18;269(7):5016-21. J Biol Chem. 1994. PMID: 7508932
-
Lymphocyte antigen receptor signal integration and regulation by the SHC adaptor.Biol Chem. 1999 Feb;380(2):129-34. doi: 10.1515/BC.1999.020. Biol Chem. 1999. PMID: 10195419 Review.
-
The GRB2/Sem-5 adaptor protein.FEBS Lett. 1994 Jan 31;338(2):113-7. doi: 10.1016/0014-5793(94)80346-3. FEBS Lett. 1994. PMID: 8307166 Review.
Cited by
-
Kinase-independent mechanisms of resistance of leukemia stem cells to tyrosine kinase inhibitors.Stem Cells Transl Med. 2014 Apr;3(4):405-15. doi: 10.5966/sctm.2012-0159. Epub 2014 Mar 5. Stem Cells Transl Med. 2014. PMID: 24598782 Free PMC article. Review.
-
Biotherapy of chronic myelogenous leukemia.Ann Hematol. 1995 Mar;70(3):113-20. doi: 10.1007/BF01682030. Ann Hematol. 1995. PMID: 7718640 Review.
-
Lyn is activated during late G1 of stem-cell-factor-induced cell cycle progression in haemopoietic cells.Biochem J. 1999 Aug 15;342 ( Pt 1)(Pt 1):163-70. Biochem J. 1999. PMID: 10432313 Free PMC article.
-
Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis.Mol Cell Biol. 1995 Oct;15(10):5531-41. doi: 10.1128/MCB.15.10.5531. Mol Cell Biol. 1995. PMID: 7565705 Free PMC article.
-
The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation.Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11746-50. doi: 10.1073/pnas.92.25.11746. Proc Natl Acad Sci U S A. 1995. PMID: 8524841 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous